A resolution expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".

Whereas more than 3,300,000 men are living with prostate cancer in the United States;
Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer in their lifetimes and 1 in 41 men in the United States will die from prostate cancer;
Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the second-leading cause of cancer-related deaths among men in the United States;
Whereas the American Cancer Society estimates that, in 2025, 313,780 men will be diagnosed with, and more than 35,770 men will die of, prostate cancer;
Whereas 35 percent of newly diagnosed prostate cancer cases occur in men under the age of 65;
Whereas the odds of developing prostate cancer rise rapidly after age 50;
Whereas having a father or brother with prostate cancer more than doubles the risk of a man developing prostate cancer, with a higher risk for men who have a brother with the disease and the highest risk for men with several affected relatives;
Whereas screening by a digital rectal examination and a prostate-specific antigen blood test may be able to detect the disease at an early stage;
Whereas, when diagnosed with localized- or regional-stage prostate cancer, the survival rate nears 100 percent;
Whereas only 37 percent of men survive more than 5 years if diagnosed with prostate cancer after the cancer has metastasized;
Whereas there are typically no noticeable symptoms of prostate cancer in the early stages, making discussions with a doctor regarding appropriate screening critical;
Whereas, in fiscal year 2025, Congress appropriated $48,551,000,000 to the National Institutes of Health, including $7,220,000,000 for the National Cancer Institute;
Whereas, in fiscal year 2025, Congress appropriated $75,000,000 for the Prostate Cancer Research Program of the Department of Defense;
Whereas the Department of Veterans Affairs has established 21 Precision Oncology Centers of Excellence in order to deliver precision oncology services to veterans suffering from prostate cancer;
Whereas ongoing research promises further improvements in prostate cancer prevention, early detection, and treatment; and
Whereas educating individuals in the United States, including health care providers, about prostate cancer and early detection strategies while emphasizing the importance of consultation with a physician regarding the benefits and risks of screening is essential to saving lives and preserving and protecting families: Now, therefore, be it
That the Senate—
expresses support for the designation of National Prostate Cancer Awareness Month;
declares that steps should be taken—
to raise awareness about the importance of screening methods for, and treatment of, prostate cancer;
to encourage research—
to improve screening and treatment for prostate cancer;
to discover the causes of prostate cancer; and
to develop a cure for prostate cancer; and
to continue to consider ways to improve access to, and the quality of, health care services for detecting and treating prostate cancer; and
calls on the people of the United States, interest groups, and affected persons—
to promote awareness of prostate cancer;
to take an active role in the fight to end the devastating effects of prostate cancer on individuals, families, and the economy; and
to observe National Prostate Cancer Awareness Month with appropriate ceremonies and activities.